Jnba Financial Advisors Novartis Ag Transaction History

Jnba Financial Advisors

$1.09 Billion
Q3 2025

A detailed history of Jnba Financial Advisors transactions in Novartis Ag stock. As of the latest transaction made, Jnba Financial Advisors holds 6,657 shares of NVS stock, worth $875,728. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,657

Previous 7,074 5.89%

Holding current value

$875,728

Previous $856,000 0.35%

% of portfolio

0.08%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 28, 2025	SELL	$113.5 - $129.73 $47,329 - $54,097	-417 Reduced 5.89%	6,657 $853,000
Q1 2025 Apr 25, 2025	SELL	$97.14 - $115.57 $61,003 - $72,577	-628 Reduced 8.15%	7,074 $788,000
Q4 2024 Jan 30, 2025	SELL	$96.78 - $117.18 $2,419 - $2,929	-25 Reduced 0.32%	7,702 $749,000
Q3 2024 Oct 30, 2024	SELL	$106.13 - $120.89 $77,368 - $88,128	-729 Reduced 8.62%	7,727 $888,000
Q2 2024 Jul 22, 2024	SELL	$92.57 - $107.37 $18,884 - $21,903	-204 Reduced 2.36%	8,456 $900,000

Q1 2024 Apr 26, 2024	SELL	$95.27 - $108.47 $2,381 - $2,711	-25 Reduced 0.29%	8,660 $837,000
Q4 2023 Feb 07, 2024	SELL	$92.27 - $101.54 $32,940 - $36,249	-357 Reduced 3.95%	8,685 $876,000
Q3 2023 Nov 02, 2023	SELL	$94.73 - $105.13 $27,282 - $30,277	-288 Reduced 3.09%	9,042 $921,000
Q2 2023 Aug 03, 2023	SELL	$92.52 - $104.91 $46,815 - $53,084	-506 Reduced 5.14%	9,330 $941,000
Q1 2023 May 01, 2023	SELL	$80.03 - $92.81 $18,006 - $20,882	-225 Reduced 2.24%	9,836 $904,000
Q4 2022 Feb 06, 2023	SELL	$75.55 - $92.52 $26,366 - $32,289	-349 Reduced 3.35%	10,061 $912,000
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $5,968 - $6,980	-80 Reduced 0.76%	10,410 $791,000
Q2 2022 Jul 22, 2022	SELL	$80.52 - $93.75 $18,680 - $21,750	-232 Reduced 2.16%	10,490 $887,000
Q1 2022 Apr 29, 2022	SELL	$80.11 - $90.62 $57,278 - $64,793	-715 Reduced 6.25%	10,722 $941,000
Q4 2021 Feb 03, 2022	SELL	$79.7 - $88.13 $7,970 - $8,813	-100 Reduced 0.87%	11,437 $1 Million
Q1 2021 May 03, 2021	BUY	$83.5 - $98.47 $10,437 - $12,308	125 Added 1.1%	11,537 $986,000
Q4 2020 Jan 25, 2021	SELL	$78.07 - $94.43 $33,882 - $40,982	-434 Reduced 3.66%	11,412 $1.08 Million
Q3 2020 Nov 05, 2020	BUY	$82.14 - $91.0 $574 - $637	7 Added 0.06%	11,846 $1.03 Million
Q4 2019 Feb 10, 2020	BUY	$84.35 - $95.37 $674 - $762	8 Added 0.07%	11,839 $1.12 Million
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $6,928 - $7,635	-81 Reduced 0.68%	11,831 $1.03 Million
Q2 2019 Jul 26, 2019	BUY	$75.4 - $92.8 $11,611 - $14,291	154 Added 1.31%	11,912 $1.09 Million
Q1 2019 May 01, 2019	BUY	$75.32 - $86.15 $68,767 - $78,654	913 Added 8.42%	11,758 $1.13 Million
Q4 2018 Feb 07, 2019	BUY	$73.66 - $82.02 $724,446 - $806,666	9,835 Added 973.76%	10,845 $931,000
Q3 2018 Nov 01, 2018	SELL	$66.94 - $77.43 $727,972 - $842,051	-10,875 Reduced 91.5%	1,010 $87,000
Q2 2018 Jul 17, 2018	SELL	$64.91 - $73.36 $12,592 - $14,231	-194 Reduced 1.61%	11,885 $898,000
Q4 2017 Jan 31, 2018	SELL	$72.33 - $77.64 $21,699 - $23,292	-300 Reduced 2.42%	12,079 $1.01 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,379	12,379 $1.03 Million

Others Institutions Holding NVS

# of Institutions

1,612

Shares Held

136M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Novartis Ag Transaction History